Balducci, Mario <br/><br/>
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Oct 2010 
 - 558-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1439-099X 
<br/><br/><label>Standard No.: </label>10.1007/s00066-010-2101-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Combined Modality Therapy--adverse effects<br/>Dacarbazine--adverse effects<br/>Female<br/>Follow-Up Studies<br/>Glioma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Radiosurgery--adverse effects<br/>Radiotherapy, Conformal--adverse effects<br/>Survival Rate<br/>Temozolomide